share_log

Benchmark Initiates Coverage On Heart Test Laboratories with Speculative Buy Rating, Announces Price Target of $8

Benchmark Initiates Coverage On Heart Test Laboratories with Speculative Buy Rating, Announces Price Target of $8

Benchmark 以投機性買入評級啓動對心臟測試實驗室的報道,宣佈目標股價爲8美元
Benzinga Real-time News ·  2022/08/08 09:44

Benchmark analyst Bruce Jackson initiates coverage on Heart Test Laboratories (NASDAQ:HSCS) with a Speculative Buy rating and announces Price Target of $8.

基準分析師布魯斯·傑克遜以投機性買入評級開始對心臟測試實驗室(納斯達克股票代碼:HSCS)進行報道,並宣佈目標股價爲8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論